Effect of Surgical Treatment on Lipid Peroxidation Parameters and Antioxidant Status in the Serum of Patients with Peripheral Arterial Disease

Table 1

Clinical characteristics of Group I patients (before surgery) and Group II patients (treated pharmacologically with simvastatin).

Parameter	Group I before surgery	Group II treated with simvastatin	𝑃 value
Total cholesterol [mmol/L]	5.9±0.9	5.1±1.1	<0.05
HDL cholesterol [mmol/L]	1.2±0.3	1.3±0.4	ns
LDL cholesterol [mmol/L]	4.2±1.5	3.0±1.1	<0.05
Triacylglycerols [mmol/L]	1.8±1.0	1.6±0.7	ns
Glucose [mmol/L]	6.6±1.9	5.6±0.8	ns
Uric acid [mg/dL]	4.9±1.2	5.4±1.4	ns
Fibrinogen [g/L]	4.4±1.8	4.1±1.1	ns
Apo A-I [g/L]	1.4±0.3	1.5±0.2	ns
Apo B [g/L]	1.0±0.2	1.1±0.2	ns
Apo B/A-I	0.8±0.2	0.7±0.2	ns
C-reactive protein [mg/L]	12.3±13.7	7.5±11.9	ns
Body mass index	25.5±4.3	23.3±3.6	ns
Age [years]	61±8	62±7	ns

HDL: high-density lipoprotein; LDL: low-density lipoprotein; Apo A-I: apolipoprotein A-I; and Apo B: apolipoprotein B.